Skip to main content

Table 3 Response rates of primary chemotherapy for clear cell carcinoma

From: Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

regimen

author

year

response/ Number of patients, response rate

Conventional Platinum-based

Goff [28]

1996

1/6, 17%

Sugiyama [29]

2000

3/27, 11%

Ho [30]

2004

4/15, 27%

Takano [9]

2006

5/30, 17%

Taxane-Platinum

Enomoto [31]

2003

2/9, 22%

Ho [30]

2004

9/16, 56%

Utsunomiya [32]

2006

8/15, 53%

Takano [9]

2006

9/28, 32%

Irinotecan-cisplatin

Takano [9]

2006

3/10, 30%